Acute renal damage after using percutaneous coronariography: related risk factors
Keywords:
acute renal lesion, contrast means, risk factors, percutaneous coronariography.Abstract
Introduction: Acute renal damage provoked due to the use of contrast means is a complication that is often underestimated from the clinical point of view. In general, there are low rates of presumption and diagnosis and it is associated with diagnostic and therapeutic interventions, as the percutaneous coronariography.
Objective: To evaluate risk factors related to the emergence of nephropathy in patients that received percutaneous coronariography.
Methods: A descriptive and analytic study of 37 patients that required percutaneous coronariography was carried out in theCardiologyCenter of "Carlos J. Finlay"Clinical-SurgicalHospital inHavana, from October, 2009 to January, 2010. Three risk groups (low, medium or high) were conformed for that purpose according to the number of present factors, and all the members were treated with physiologic saline solution to 1 mL/kg/h. The existence of acute renal damage was determined if a 25% increment or more of seric creatinin took place at 72 hours of having practiced the procedure, in comparison with the figures obtained initially.
Results: Nephropathy was just induced in 4 patients (10.8%), 3 of which belonged to the high risk group. There was no affectation in the members of the low risk group.
Conclusions: The results of this study suggested the presence of risk factors that condition the emergence of a nephropathy after using percutaneous coronariography, mainly if two or more converge in the same patient.
Downloads
References
2. Silver SA, Shah PM, Chertow GM, Harel S, Wald R, Harel Z. Risk prediction models for contrast induced nephropathy: systematic review. BMJ. 2015; 351:4395.
3. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008; 3(3): 844-61.
4. Sudarsky D, Nikolsky E. Contrast-induced nephropathy in interventional cardiology. Int J Nephrol Renovasc Dis. 2011; 4: 85-99.
5. Ferreira Morales JL. Actualidad en nefropatía por medio de contraste. Nefrol Latinoam. 2017; 14(2): 69-78.
6. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105(19): 2259-64.
7. James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, et al. Contrast-induced acute kidney injury and risk of adverse clinical out comes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013; 6(1): 37-43.
8. Junta de Andalucía. Protocolo para la prevención de la nefropatía por contraste para pacientes en medio hospitalario. 2013. Andalucía: Consejería de Salud y Bienestar Social; 2013 [citado 20 Sep 2017]. Disponible en: http://www.juntadeandalucia.es/servicioandaluzdesalud/hinmaculada/web/servicios/mi/FICHEROS/documentos%20de%20interes/Acuerdos%20con%20otras%20UGC/PROTOCOLO%20CONTRASTE%20YODADO%202013.pdf
9. Weisbord SD, Palevsky PM. Prevention of contrast- induced acute kidney injury. J Clin Outcom Manag. 2012 [citado 20 Sep 2017]. Disponible en: http://www.jcomjournal.com/prevention-of-contrast-induced-acute-kidney-injury/
10. Singh N, Lee JZ, Huang JJ, Low SW, Howe C, Pandit A, et al. Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart. 2014 [citado 20 Sep 2017]; 1(1). Disponible en: http://openheart.bmj.com/content/openhrt/1/1/e000127.full.pdf
11. Sinert R, Doty CI. Update: prevention of contrast-induced nephropathy in the emergency department. Ann Emerg Med. 2009; 54(1): 1-5.
12. Ozkok S, Ozkok A. Contrast-induced acute kidney injury: A review of practical points. World J Nephrol. 2017; 6(3): 86-99.
13. Cicin I, Erdogan B, Gulsen E, Uzunoglu S, Sut N, Turkmen E, et al. Incidence of contrast-induced nephropathy in hospitalised patients with cancer. Eur Radiol. 2014; 24(1): 184-90.
14. Chalikias G, Drosos L, Tziakas DN. Contrast-induced acute kidney injury: an update. Cardiovasc Drugs Ther. 2016; 30(5): 215–28.
15. World Medical Association. WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. 64th WMA General Assembly, Fortaleza, Brazil, October 2013 [citado 15 Sep 2017]. Disponible en: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
16. Cuba. Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2016. La Habana: MINSAP; 2017 [citado 20 Sep 2017]. Disponible en: http://files.sld.cu/dne/files/2017/05/Anuario_Estad%C3%ADstico_de_Salud_e_2016_edici%C3%B3n_2017.pdf
17. Briguori C, Donnarumma E, Quintavalle C, Fiore D, Condorelli G. Contrast-induced acute kidney injury: potential new strategies. Curr Opin Nephrol Hypertens. 2015; 24(2): 145-53.
18. Sadat U, Usman A, Boyle JR, Hayes PD, Solomon RJ. Contrast Medium-Induced Acute Kidney Injury. Cardio Renal Med. 2015; 5(3): 219-28.
19. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-9.
20. Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016; 102(8): 638-48.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
